title: Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy.
authors.forename: I
authors.initials: I
authors.lastname: Pellegrin
authors.forename: M
authors.initials: M
authors.lastname: Segondy
authors.forename: I
authors.initials: I
authors.lastname: Garrigue
authors.forename: J
authors.initials: J
authors.lastname: Izopet
authors.forename: B
authors.initials: B
authors.lastname: Montes
authors.forename: J L
authors.initials: JL
authors.lastname: Pellegrin
authors.forename: J
authors.initials: J
authors.lastname: Reynes
authors.forename: P
authors.initials: P
authors.lastname: Massip
authors.forename: J
authors.initials: J
authors.lastname: Puel
authors.forename: H
authors.initials: H
authors.lastname: Fleury
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D016049:Didanosine / Q000494:pharmacology / Q000627:therapeutic use; D004352:Drug Resistance, Microbial / Q000235:genetics; D018432:Drug Resistance, Multiple / Q000235:genetics; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D054303:HIV Reverse Transcriptase / Q000235:genetics; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D006801:Humans; D009154:Mutation; D010641:Phenotype; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D018119:Stavudine / Q000494:pharmacology / Q000627:therapeutic use; D019562:Viral Load; D015215:Zidovudine / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D018119:Stavudine; D054303:HIV Reverse Transcriptase; D016049:Didanosine